RBAK inhibitors are a class of chemical compounds designed to specifically target and inhibit the function of RBAK, a protein involved in transcriptional regulation and cellular signaling. RBAK, also known as Repressor of the RB Transcriptional Corepressor, is associated with the regulation of gene expression through its interaction with the retinoblastoma (RB) protein. RBAK functions as a transcriptional repressor by binding to the RB protein and other transcriptional machinery, thereby influencing the expression of genes that control cell cycle progression, differentiation, and growth. It plays a crucial role in maintaining cellular homeostasis by modulating the transcription of genes that are involved in critical cellular processes. Inhibitors of RBAK disrupt its ability to interact with the RB protein and other components of the transcriptional complex, thereby altering the normal transcriptional repression activity.
Inhibition of RBAK can lead to changes in the expression of genes that are typically repressed by this protein, particularly those involved in the regulation of cell proliferation and differentiation. By blocking RBAK's function, these inhibitors interfere with the molecular pathways that control gene silencing, allowing for the potential activation of previously repressed genes. Researchers utilize RBAK inhibitors to study the specific role of RBAK in transcriptional regulation, providing insights into how it interacts with the RB protein and other regulatory factors to influence gene expression. These inhibitors are valuable tools for investigating the broader mechanisms of transcriptional control, helping scientists understand the complex interactions between transcriptional repressors and their target genes. Additionally, RBAK inhibitors shed light on the importance of transcriptional repressors in regulating the balance between cell growth and quiescence, offering deeper insights into the molecular pathways that maintain cellular function and prevent uncontrolled cell proliferation. Through these studies, researchers can further explore the role of RBAK in maintaining the regulation of critical cellular processes at the transcriptional level.
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY 294002 may decrease RBAK gene expression by inhibiting PI3K, which is pivotal in the AKT signaling pathway that promotes transcriptional activation of several genes, including potentially the RBAK gene. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $65.00 $210.00 | 26 | |
2-Deoxy-D-glucose could inhibit RBAK expression by interfering with glycolysis, leading to cellular energy deficits that result in a downregulation of transcriptional processes, including those governing the expression of the RBAK gene. | ||||||